MHL Offers Insight at the FDA Public Hearing
We’re proud to announce that Mile High Labs has been selected to speak at the FDA Public Hearing for Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds. Our Founder and CTO, Stephen Mueller, will be speaking to the panel about Mile High’s core values and our recommendations for the future of CBD regulation.
The event will be taking place on May 31, 2019 from 8:00 AM EDT – 6:00 PM EDT. You can view a recap of the hearing down below.